[1] 中华医学会儿科学分会肾脏病学组. 儿童常见肾脏疾病诊治循证指南(一)：激素敏感、复发/依赖肾病综合征诊治循证指南(试行) [J]. 中华儿科杂志，2009，47(3)：167-170. [2] 中华医学会儿科学分会肾脏病学组. 儿童常见肾脏疾病诊治循证指南(试行)(三)：激素耐药型肾病综合征诊治指南 [J]. 中华儿科杂志，2010，48(1)：72-75. [3] Lombel RM，Hodson EM，Gipson DS. Treatment of steroid-resistant nephrotic syndrome in children：new guidelines from KDIGO [J]. Pediatr Nephrol，2013，28(3)：409-414. [4] Abramowicz M，Barnett HL，Edelmann CM Jr，et al. Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children [J]. Lancet，1970，1(7654)：959-961. [5] 朱光华，杨友，俞全胜，等. 激素耐药肾病的几种病理类型 [J]. 临床儿科杂志，2005,23(4)：220-221. [6] Gargah T，Labassi A，Goucha-Louzir R，et al. Histopathological spectrum of childhood idiopathic steroid-resistant nephrotic syndrome in Tunisia [J]. Tunis Med，2011 89(3)：258-261. [7] Mubarak M，Kazi JI，Shakeel S，et al. The spectrum of histopathological lesions in children presenting with steroid-resistant nephrotic syndrome at a single center in Pakistan [J]. ScientificWorldJournal，2012，2012：681802. [8] 黄爱文，何庆南，周频，等. 儿童激素耐药型与激素敏感型肾病综合征尿蛋白组学的初步研究 [J]. 中国当代儿科杂志，2009，11(5)：341-345. [9] Bai Y，Liu W，Guo Q，et al. Screening for urinary biomarkers of steroid-resistant nephrotic syndrome in children [J]. Exp Ther Med，2013，5(3)：860-864. [10] Youssef DM，Elbehidy RM，Abdelhalim HS，et al. Soluble interleukine-2 receptor and MDR1 gene expression levels as inflammatory biomarkers for prediction of steroid response in children with nephro-tic syndrome [J]. Iran J Kidney Dis，2011，5(3)：154-161. [11] 王荧荧，丁桂霞，袁杨刚，等. 尿α1抗胰蛋白酶预测儿童原发性肾病综合征激素治疗的疗效 [J]. 中华肾脏病杂志，2012，28(11)：857-862. [12] Piyaphanee N，Ma Q，Kremen O，et al. Discovery and initial validation of α 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome [J]. Proteomics Clin Appl，2011，5(5-6)：334-342. [13] Mishra OP，Jain P，Srivastava P，et al. Urinary N-acetyl-beta-D glucosaminidase (NAG) level in idiopathic nephrotic syndrome [J]. Pediatr Nephrol，2012，27(4)：589-596. [14] Bennett MR，Piyaphanee N，Czech K，et al. NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome [J]. Pediatr Nephrol，2012，27(5)：807-812. [15] Trachtman H. Biomarkers of therapeutic response in primary nephro-tic syndrome [J]. Pediatr Nephrol，2013，28(1)：159. [16] Luo Y，Wang C，Chen X，et al. Increased serum and urinary micro-RNAs in children with idiopathic nephrotic syndrome [J]. Clin Chem，2013，59(4)：658-666. [17] Wei C，El Hindi S，Li J，et al. Circulating urokinase receptor as a cause of focal segmental glomerulusclerosis [J]. Nat Med，2011，17(8)：952-960. [18] Wei C，Trachtman H，Li J，et al. Circulating suPAR in two cohorts of primary FSGS [J]. J Am Soc Nephrol，2012，23(12)：2051-2059. [19] Mori K，Honda M，Ikeda M. Efficacy of methylprednisolone pulse therapyin steroid-resistant nephrotic syndrome [J]. Pediatr Nephrol，2004，19(11)：1232-1236. [20] Shenoy M，Plant ND，Lewis MA，et al. Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome [J]. Pediatr Nephrol，2010，25(5)：899-903. [21] Habashy D，Hodson E，Craig J. Interventions for idiopathic steroid-resistant nephritic syndrome in children [DB/OL]. Cochrane Database Syst Rev，2004，(2)：CD003594. [22] Cucer F，Miron I，Müller R，et al. Treatment with cyclophoshamide for steroid-resistant nephritic syndrome in children [J]. Maedica (Buchar)，2010，5(3)：167-170. [23] Tahar G，Rachid LM. Cyclosporine A and steroid therapy in childhood steroid-resistant nephritic syndrome [J]. Int J Nephrol Renovasc Dis，2010，3：117-121. [24] Hodson EM，Willis NS，Craig JC. Interventions for idiopathic steroid-resistant nephrotic syndrome in children [DB/OL]. Cochrane Database Syst Rev，2010,10(11)：CD003594. [25] Büscher AK，Kranz B,Büscher R，et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome [J]. Clin J Am Soc Nephrol，2010，5(11)：2075-2084. [26] Stefanidis CJ，Querfeld U. The podocyte as a target：cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations [J]. Eur J Pediatr，2011，170(11)：1377-1383. [27] Ghiggeri GM,Catarsi P，Scolari F，et al. Cyclosporine in patients with steroid-resistant nephritic syndrome：an open-label，nonrandomized，retrospective study [J]. Clin Ther，2004，26(9)：1411-1418. [28] Wang W，Xia Y，Mao J，et al.Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome [J]. Pediatr Nephrol，2012，27(11)：2073-2079. [29] Supavekin S，Surapaitoolkorn W，Kurupong T，et al. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome [J]. J Med Assoc Thai. 201，96(1)：33-40. [30] Roberti I，Vyas S. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus [J]. Pediatr Nephrol，2010，25(6)：1117-1124. [31] Morgan C，Sis B，Pinsk M，et al. Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome [J]. Nephrol Dial Transplant，2011，26(9)：2860-2865. [32] 姚盛华，毛建华，夏永辉. 他克莫司联合小剂量激素治疗儿童激素抵抗型肾病综合征21例临床分析 [J]. 中华儿科杂志，2011，49(11)：825-828. [33] Gulati A，Sinha A，Gupta A，et al. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome [J]. Kidney Int，2012，82(10)：1130-1135. [34] Li Z，Duan C，He J，et al. Mycophenolate mofetil therapy for children with steroid-resistant nephritic syndrome [J]. Pediatr Nephrol，2010，25(5)：883-888. [35] Gargah TT，Lakhoua MR. Mycophenolate mofetil in treatment of childhood steroid-resistant nephritic syndrome [J]. J Nephrol，2011，24(2)：203-207. [36] Nickavar A，Safarzadeh AE，Sotoudeh K，et al. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children [J]. Iran J Kidney Dis，2012，6(5)：346-349. [37] Nikibakhsh AA，Mahmoodzadeh H，Karamyyar M，et al. Treatment of steroid and cyclosporine-resistant idiopathic nephritic syndrome in children [J]. Int J Nephrol，2011,2011：930-965. [38] de Mello VR，Rodrigues MT，Mastrocinque TH，et al. Mycophenolate mofetil in children with steroid/cyclophosphamide-resistant nephrotic syndrome [J]. Pediatr Nephrol，2010，25(3)：453-460. [39] Gellermann J，Ehrich JH，Querfeld U. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome [J]. Nephrol Dial Transplant，2012，27(5)：1970-1978. [40] Prytu?a A，Iijima K，Kamei K，et al. Rituximab in refractory nephro-tic syndrome [J]. Pediatr Nephrol，2010，25(3)：461-468. [41] Gulati A，Sinha A，Jordan SC，et al. Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome：multicentricreport [J]. Clin J Am Soc Nephrol，2010，5(12)：2207-2212. [42] Ito S，Kamei K，Ogura M，et al. Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome [J]. Pediatr Nephrol，2013，28(2)：257-264. [43] Sato M，Ito S，Ogura M, et al. Atypical Pneumocystis jiroveci pneu-monia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome [J]. Pediatr Nephrol，2013，28(1)：145-149. [44] Straatmann C，Ayoob R，Gbadegesin R，et al. Treatment outcome of late steroid-resistant nephrotic syndrome：a study by the Midwest Pediatric Nephrology Consortium [J]. Pediatr Nephrol，2013，28(8)：1235-1241. [45] 夏正坤，金玉，鹿玲. 儿童常见肾脏疾病诊治循证指南（试行）解读（三）：激素耐药型肾病综合征诊治［J］. 中华儿科杂志，2010，48（1）：76-78.
